What are liver hemangiomas, what causes them, and how are they treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Liver Hemangiomas: Diagnosis, Causes, and Treatment

Liver hemangiomas are benign vascular tumors that rarely require treatment unless they are large, symptomatic, or show rapid growth. 1

What Are Liver Hemangiomas?

  • Hepatic hemangiomas are the most common benign liver tumors, consisting of clusters of blood-filled cavities lined by endothelial cells and fed by the hepatic artery 2
  • Prevalence estimates range from 0.4% to 8% of the general population, with higher prevalence in women 3
  • They are considered developmental malformations of vascular origin rather than true neoplasms 3
  • Based on size, they can be categorized as:
    • Small (<2 cm): Typically appear uniformly echogenic on ultrasound 3
    • Medium (2-5 cm): Mainly echogenic on imaging 3
    • Large/Giant (>5 cm): Show mixed echogenicity and have higher risk of complications 3, 1

Causes and Risk Factors

  • The exact pathophysiology of liver hemangiomas is not fully understood, but they are considered congenital vascular malformations 4
  • Unlike hepatocellular adenomas, liver hemangiomas do not have a well-established association with estrogen exposure, though they are more common in women 3
  • Genetic factors may play a role, but specific genetic markers have not been clearly identified 4
  • Most hemangiomas are discovered incidentally during imaging studies performed for unrelated conditions 2

Diagnosis

  • Most hemangiomas are asymptomatic and discovered incidentally on imaging 2
  • Diagnostic imaging features include:
    • Ultrasound: Small hemangiomas appear uniformly echogenic, while larger ones show mixed echogenicity 3
    • Contrast-enhanced ultrasound (CEUS): Shows characteristic peripheral nodular enhancement (74%) in arterial phase and complete (78%) or incomplete (22%) centripetal filling in portal venous and late phases 3
    • MRI: Preferred for inconclusive cases with 95-99% accuracy for diagnosing hemangiomas 1
  • Biopsy is generally not recommended due to bleeding risk and is only necessary when imaging is inconclusive and malignancy cannot be excluded 1

Treatment Approach

  • The vast majority of liver hemangiomas require no treatment as they are asymptomatic and follow a benign course 1, 5
  • Treatment decisions should be based on:
    • Size: Giant hemangiomas (>5 cm) have higher risk of complications 1
    • Symptoms: Abdominal pain or compression of adjacent structures 5
    • Growth rate: Rapidly enlarging lesions may warrant intervention 1
    • Complications: Rupture (rare but serious) 1, 6

Management Algorithm:

  1. For asymptomatic, typical hemangiomas <5 cm:

    • No intervention required 1
    • No routine follow-up needed 1
  2. For giant hemangiomas (>5 cm):

    • If asymptomatic: Observation with periodic imaging 1
    • If symptomatic or growing: Consider intervention 1, 5
  3. For symptomatic hemangiomas:

    • Surgical options: Enucleation (preferred) or hepatic resection 7
    • Non-surgical options: Transcatheter arterial embolization or radiofrequency ablation 4
  4. For pregnant women with hemangiomas:

    • Small/medium hemangiomas: Generally safe with no monitoring required 3
    • Giant cavernous hemangiomas (>5-10 cm): Monitoring recommended during pregnancy 3
    • For very large hemangiomas (>10 cm) in women planning pregnancy: Consider treatment before conception 1

Complications and Special Considerations

  • Rupture is rare (<1% overall) but risk increases with size (3.2% for lesions >4 cm, 5% for lesions >10 cm) 1
  • Peripherally located and exophytic lesions have higher rupture risk 1
  • During surgical management of giant hemangiomas, early vascular control techniques are essential to minimize bleeding risk 7
  • Unlike hepatocellular adenomas, hemangiomas have no risk of malignant transformation 5

References

Guideline

Management of Incidentally Detected Liver Hemangiomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatic hemangioma -review-.

Journal of medicine and life, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hepatic hemangioma: What internists need to know.

World journal of gastroenterology, 2020

Research

Benign Liver Tumors.

Visceral medicine, 2020

Research

A case of a ruptured sclerosing liver hemangioma.

International journal of hepatology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.